Feedback plc Stock
Your prediction
Pros and Cons of Feedback plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Feedback plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Feedback plc | 1.480% | -2.174% | 31.068% | -56.169% | -32.500% | -93.250% | -92.500% |
| Allerthal-werke-Ag | -0.770% | 0.000% | 4.000% | 14.035% | 20.370% | 10.169% | -9.091% |
| Cfc Industriebeteiligungen | 3.810% | -19.231% | 10.759% | -35.976% | 34.615% | -61.679% | -36.364% |
| Gatekeeper Systems Inc | 5.660% | -10.372% | 11.571% | 13.789% | -22.373% | 275.410% | 113.271% |
News
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type
